AK
Highly rated in
33
conditions
Highly rated in
33
conditions
Check Dr. Asha Karippot's experience treating your condition:
About Dr. Asha Karippot

Asha Karippot is a Hematologist Oncology specialist and an Oncologist in Tulsa, Oklahoma. Karippot has been practicing medicine for over 20 years and is highly rated in 33 conditions, according to our data. Her top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, and Wilms Tumor. She is licensed to treat patients in Texas and Oklahoma. Karippot is currently accepting new patients.

Her clinical research consists of co-authoring 6 peer reviewed articles and participating in 5 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Asha Karippot it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Dr. Asha Karippot accepts the following insurance:

  •  Blue Cross Blue Shield
  •  Ambetter
  •  Bright Health
  •  Oscar
  •  Superior HealthPlan
Locations
10109 E. 79th Street, Tulsa, OK 74133
Background & Education
Graduate Institution
Other, 2002
Specialties
Hematology Oncology
Oncology
Hematology
Licenses
Internal Medicine in TX
Hospital Affiliations
Baylor Scott & White Medical Center - Plano
Cumberland County Hospital
Baylor Scott & White The Heart Hospital Baylor - Plano
Baylor Scott & White Medical Center - McKinney
Medical City Plano
Languages Spoken
English
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


5 Clinical Trials

DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors
A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers
View 2 Less Clinical Trial -

6 Total Publications

Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors